A Clinical Trial Assessing Safety of MF101 for Hot Flushes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This Phase 1, open label, randomized clinical trial will enroll 40 generally healthy, postmenopausal women aged 40-65 years old. Women will be randomized to one of two oral doses of MF101 for 4 weeks. Participants will be recruited at 3 clinical sites in the United States.
Epistemonikos ID: 6a6345c69f240e4c4b360c08ae3995a81900fc97
First added on: May 06, 2024